Cargando…
Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
SIMPLE SUMMARY: Proton pump inhibitors (PPIs) are commonly used for acid reduction in peptic ulcer diseases and esophageal reflux diseases. The effects of changing gut microbiota, and prolonged hypergastrinemia were reported. This study demonstrated that long-term PPI use in CRC patients was associa...
Autores principales: | Wu, Chin-Chia, Fang, Chuan-Yin, Yu, Ben-Hui, Chang, Chun-Ming, Hsu, Ta-Wen, Hung, Chung-Lin, Hung, Shih-Kai, Chiou, Wen-Yen, Tsai, Jui-Hsiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648487/ https://www.ncbi.nlm.nih.gov/pubmed/37958477 http://dx.doi.org/10.3390/cancers15215304 |
Ejemplares similares
-
Is Colectomy Associated with the Risk of Type 2 Diabetes in Patients without Colorectal Cancer? A Population-Based Cohort Study
por: Wu, Chin-Chia, et al.
Publicado: (2021) -
Association of Increased Risk of Pneumonia and Using Proton Pump Inhibitors in Patients With Type II Diabetes Mellitus
por: Lin, Wen-Ling, et al.
Publicado: (2019) -
Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease
por: Hung, Chung-Lin, et al.
Publicado: (2015) -
Proton Pump Inhibitor Use is Associated With Risk of Pancreatic
Cancer: A Nested Case–Control Study
por: Peng, Yen-Chun, et al.
Publicado: (2018) -
Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients
por: de Francisco, Angel L.M., et al.
Publicado: (2017)